WIB-Pittsburgh: Artificial Lungs – From Bench to Bedside
View Registrations Tell a Friend About This EventTell a Friend
WIB-Pittsburgh: Artificial Lungs – From Bench to Bedside

9/23/2020
When: Wednesday, September 23, 2020
5:30 p.m. – 6:30 p.m. EDT
Where: Online (Zoom)
Contact: WIB-Pittsburgh


Online registration is closed.
« Go to Upcoming Event List  

Laura Lund will present her career path from bioengineer to clinical research executive at ALung Technologies. ALung is a startup company established in 1998 to commercialize artificial lung technology developed at the University of Pittsburgh. As a graduate student in the Artificial Lung Lab at the University of Pittsburgh, Dr. Lund spent many years researching blood gas exchange technologies that served as the foundation for the Hemolung Respiratory Assist System, the artificial lung device currently being commercialized by ALung.

In this presentation, Dr. Lund will tell the story of ALung Technologies, the Hemolung device, and how her career path at ALung has provided her with the opportunity to be at the bedside of patients whose lives have been saved by the very device she began her career researching. Currently, the Hemolung Respiratory Assist System has received Emergency Use Authorization by the FDA for the treatment of patients hospitalized for severe cases of COVID-19.

 

Disclaimer: This event may be recorded. If so, there is a possibility your image and or voice may be a part of that recording. If you do not wish for your image to be included please turn off your camera.

 

Speaker Bio

Laura Lund, Ph.D. 
Vice President of Scientific Affairs, ALung Technologies

Laura Lund earned a B.S. in Mechanical Engineering from Yale University in 1988 and after a brief two years at Westinghouse Nuclear Services, returned to academia, earning a Ph.D. in Bioengineering at the University of Pittsburgh. She completed her degree in 2000 after having worked for over 8 years in the Artificial Lung Lab at the McGowan Institute of Regenerative Medicine. Dr. Lund spend the next phase of her career teaching undergraduate engineering at the University of Pittsburgh. In 2011, she transitioned to industry, accepting a position at ALung Technologies as a Clinical Scientist. She is currently the Vice President of Clinical Science at ALung and is leading the effort to complete a large clinical trial on the path to obtaining FDA clearance of the Hemolung Respiratory Assist System, an artificial lung based on technology derived from the very same University of Pittsburgh Artificial Lung Lab.

   

Pricing Information

  • Members: Free
  • Limited Free Guest Registration (Non-member)*: $20
  • Optional Donation: $20

*Click here to purchase a WIB membership.

 
Note: Zoom meeting link will be sent along with confirmation email, after registration has been completed.


Special Pricing

Members can register guests at member price.

 

Event Capacity

100